NewsRoom Articles - Page 1376 of 1408

TuesdayNov 22, 2016 9:21 am

Conatus Pharmaceuticals, Inc. (CNAT) is “One to Watch”

Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT), a biotechnology company focused on the development and commercialization of new medicines to treat a variety of liver diseases, recently announced its results for the third quarter of 2016 ended September 30. The focus has been on the development of its lead compound, Emricasan, an orally active pan-caspase protease inhibitor that should reduce the activity of human caspases, the enzymes that mediate inflammation and apoptosis. CNAT believes that by reducing the activity of these enzymes, its compound, Emricasan, can interrupt the progress of liver disease and provide potential treatments. In terms of financial results, the…

MondayNov 21, 2016 3:13 pm

Vanda Pharmaceuticals, Inc. (VNDA) Receives Consensus Rating of “Buy”

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of pharmaceutical products to help in the treatment of central nervous system disorders, now has a product portfolio made up of HETLIOZ® (tasimelteon), Fanapt® (iloperidone), Tradipitant (VLY-686), Trichostatin A, and AQW051, all of which address high unmet medical needs and improve the lives of patients. The company recently released its financial results for the third quarter of 2016 (ended September 30) highlighting that total revenues grew to $38.5 million, an increase of 7% over the second quarter of this year. This was also a 36% increase…

MondayNov 21, 2016 1:13 pm

Cogint, Inc. (COGT) is “One to Watch”

Distilling complexity into actionable intelligence is the core focus for recently rebranded data analytics outfit Cogint, Inc. (NASDAQ: COGT). Cogint rang the NASDAQ bell (http://nnw.fm/B0Swh) only a handful of days after transitioning shares over to the exchange, amid a big push by the company to secure and expand an increasingly dominant footprint in massive scale, people-based digital marketing and customer acquisition solutions via its Fluent (http://nnw.fm/Q2iP0) subsidiary. Fluent is a data-driven performance marketing suite powered by the same proprietary, next-gen data fusion platform known as CORE™, which also powers the company’s analytical and risk management solutions. Fluent is changing the…

MondayNov 21, 2016 10:18 am

Professional Diversity Network, Inc. (IPDN) Closes Stock Sale Transaction with Cosmic Forward Limited

In a recent news release by Professional Diversity Network, Inc. (NASDAQ: IPDN), it was announced that Cosmic Forward Limited (“CFL”), a Seychelles-based private company, now owns 51% of the Internet software and services company, which specializes in providing career networking for women and diverse professionals. IPDN recently completed the sale of 1,777,417 shares of its common stock to CFL for $9.60 per share, generating gross proceeds of approximately $17.1 million, prior to expenses and debt repayment. The capital, along with the newly-formed strategic partnership, is expected to play a role in IPDN’s efforts to expand its operations into a number…

MondayNov 21, 2016 9:49 am

Park Place Energy (PKPL) Expects Exponential Growth after Turkish Assets Acquisition

Park Place Energy, Inc. (OTCQB: PKPL), a Texas-based gas and oil exploration company focused on running international development and exploration projects, anticipates significant growth in terms of cash flow and share prices once it completes the acquisition of three oil and gas companies in Turkey next month. The company, which already has an established presence and offices in the Balkan region via its gas exploration in northeast Bulgaria, entered a purchase agreement with Tiway Oil B.V. in December of last year for the acquisition of three Tiway subsidiaries controlling three oil and gas explorations in Turkey – one offshore and…

MondayNov 21, 2016 9:16 am

GainClients, Inc. (GCLT) is “One to Watch”

GainClients, Inc. (OTC: GCLT) is a software service company focused primarily on the development of marketing services for real estate professionals and valuable home search and area information tools for consumers. The company’s innovations expound the popularity of online networks by helping real estate professionals better serve their clients through the sharing of accurate real estate data. The company’s main product is the GCard progressive networking system, which is designed to build and promote relationships among real estate professionals and their clients. Using the GCard, agents and brokers have the means to offer real estate, lending and title services information…

FridayNov 18, 2016 2:32 pm

Ampio Pharmaceuticals, Inc. (AMPE) Targeting Common Inflammatory Conditions with Two Late-Stage Product Candidates

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. The company’s development pipeline currently features two product candidates advancing through late-stage clinical trials in the United States, including Ampion™ for the treatment of osteoarthritis of the knee (OAK) and Optina™ for the treatment of diabetic macular edema (DME). Osteoarthritis, the most common form of arthritis, currently affects more than 100 million people in the United States alone, with over 48 million suffering from OAK. Meanwhile,…

FridayNov 18, 2016 11:06 am

Medical Transcription Billing, Corp. (MTBC) Announces Monthly Dividend on Series A Preferred Stock

Before the opening bell, Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ: MTBCP) announced that its board of directors has declared monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock for December, January and February. These monthly dividends will be valued at roughly $0.23 per share, or 11% of the $25 per share liquidation preference, and will be made payable on the 15th day of the following month. The applicable record date for the newly-announced dividends will be the last day of the relevant calendar month. News of the dividends comes just over a week after MTBC…

FridayNov 18, 2016 9:49 am

CytoSorbents Corp. (CTSO) is “One to Watch”

November has been a promising month for CytoSorbents Corp. (NASDAQ: CTSO), a critical care immunotherapy company. The New Jersey-based company, specializing in blood purification to control deadly inflammation in critically ill and cardiac surgery patients, reported its financial results for the third quarter ended September 30, 2016. CTSO reported that product sales for the third quarter of this year were up to $2.14 million, a new record, marking the sixth quarter in a row to show substantial growth with sales up by 100% from 2015’s $1.07 million. The jump was attributed to increases in both direct sales and sales through…

ThursdayNov 17, 2016 3:58 pm

Inovio Pharmaceuticals, Inc. (INO) opens New Front Line in War against Cancer & Infectious Diseases with DNA Vaccines

Over 2,000 years ago, Plato, in his immortal Socratic dialogue, had the great philosopher express his astonishment at the new diseases plaguing Athenian society and their bizarre and horrible names. Our position today is very similar. Strange, horrible afflictions with bizarre, frightening names like cancer, Ebola and Zika, unknown or unrecognized until modern times, threaten us with epidemics and pandemics. For a hundred years or so, we’ve fought them off with traditional vaccines and pharmaceuticals. Now, a new battlefront is set to open with the advent of DNA vaccines from companies like Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Traditional vaccines stimulate…

Financial news and publishing for public and private companies

Contact us: 512.354.7000